Clinical Trials Browser

Observational × orelabrutinib × Clear all

NCT05495828 2023-10-26

Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors

Lymphoma, B-Cell

NCT06015464 2023-08-29

An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL

Lymphoma